Abeona Therapeutics Announces Leadership and Board Transitions
NEW YORK and CLEVELAND, Sept. 28, 2020 (GLOBE NEWSWIRE) — Abeona Therapeutics Inc. (Nasdaq: ABEO), a fully-integrated leader in gene […]
WSFS Wealth Study Finds Area Residents are Cautious but Confident in Their Investments Despite the Pandemic
WILMINGTON, Del., Sept. 28, 2020 (GLOBE NEWSWIRE) — Local consumers planning for the future believe they have weathered market fluctuations […]
Chicken Soup for the Soul Entertainment Announces New Originals and Exclusives, Movies, and Series for Crackle Plus for October
COS COB, Conn., Sept. 28, 2020 (GLOBE NEWSWIRE) — Chicken Soup for the Soul Entertainment Inc. (Nasdaq: CSSE), one of the […]
Barron’s Ranks LPL Financial-Affiliated Rias Among Top 100 Firms
CHARLOTTE, N.C., Sept. 28, 2020 (GLOBE NEWSWIRE) — LPL Financial LLC, a leading retail investment advisory firm, independent broker-dealer and […]
U.S. Enterprises Adopt Containers in Cloud Native Computing
STAMFORD, Conn., Sept. 28, 2020 (GLOBE NEWSWIRE) — U.S. enterprises are embracing cloud native, container-based computing but still face challenges […]
Novavax to Present COVID-19, Influenza and RSV Candidate Vaccine Data at World Vaccine Congress Washington 2020
GAITHERSBURG, Md., Sept. 28, 2020 (GLOBE NEWSWIRE) — Novavax, Inc. (Nasdaq: NVAX), a late stage biotechnology company developing next-generation vaccines […]
Sorrento Releases Positive Results of Phase 1B Trial of Resiniferatoxin (RTX) In Reduction of OsteoArthritis (OA) Knee Pain
Phase 1b safety data at 6 month post-administration and Day 84 efficacy data available for all patients enrolled.No dose limiting […]
Hurricane Grill & Wings Makes Debut in California
For the first time, favorite laid-back tropical wing brand enters the Golden StateChula Vista, CA, Sept. 28, 2020 (GLOBE NEWSWIRE) […]
Sarepta Therapeutics Investigational Gene Therapy SRP-9003 for the Treatment of Limb-Girdle Muscular Dystrophy Type 2E Shows Sustained Functional Improvements 18-months After Administration
— Continued functional improvements were observed at 18 months in the low–dose cohort — — First look at functional outcomes in […]
Sarepta Therapeutics Reports Sustained Functional Improvement Two Years After Treatment with SRP-9001, its Investigational Micro-dystrophin Gene Therapy for Duchenne Muscular Dystrophy
–Results demonstrate continued safety and tolerability of SRP-9001 in four participants with Duchenne —–All four participants demonstrated improvements in NSAA […]
